Regulatory

Wyss Center Partners with BrainScape Medical to License Groundbreaking Epios® Technology

The collaboration aims to drive long-term brain monitoring and neurostimulation innovations into clinical applications....Read more

06th February, 2025


BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value

Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation ...Read more

06th February, 2025


Womens Wellness brand NUA Raises Rs 35 Crore in Pre-Series C led by Mirabilis Investment Trust

● Round also saw participation from notable investors including Samir Singh, EVP - Asia, Colgate Palmolive & Former Chair of Unilever SE Asia, Shuchi Kothari, Head of DSP Family Office and SRF Limited ● ...Read more

06th February, 2025


EyeYon Medical expands operations with New Subsidiary in China

The move aims to strengthen EyeYon’s presence in Asia and enhance access to its innovative ophthalmic solutions....Read more

05th February, 2025


FDA approves Roche’s Susvimo as first continuous delivery treatment for Diabetes-Related Blindness

Susvimo becomes the only FDA-approved therapy offering continuous drug delivery for diabetic eye disease....Read more

05th February, 2025


Gyder Surgical secures FDA 510(k) clearance for GYDER® Hip System

World’s first pin-less, image-less solution for precise acetabular cup positioning in anterior hip arthroplasty....Read more

04th February, 2025


Median Technologies' eyonis™ LCS Achieves Primary Endpoint in RELIVE Trial

Successful results from the pivotal study pave the way for regulatory submissions in lung cancer screening....Read more

03rd February, 2025


Intelligent Bio Solutions expands global reach with Drug Screening System upgrade

The enhanced system now supports multiple languages, improving accessibility for global drug screening operations....Read more

03rd February, 2025


QR678® Partners with Spectra Medical to Expand Access Nationwide

The partnership aims to make QR678®'s advanced, non-surgical hair regrowth treatment more accessible across the country through Spectra Medical’s distribution network. ...Read more

31st January, 2025


Vertex Secures FDA Approval for JOURNAVX™ (suzetrigine), a Novel Non-Opioid Treatment for Acute Pain

JOURNAVX™ introduces a first-in-class approach to managing moderate-to-severe acute pain, offering an alternative to traditional opioid therapies....Read more

31st January, 2025


© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer